Key result
Nebulised salbutamol therapy produced a >20% fall in respiratory resistance in 18 of 20 wheezing children over 20 months of age, but no child under 18 months showed a >5% fall.
Why the study?
Does nebulised salbutamol improve respiratory resistance in wheezing children aged 7 months to 3 years 7 months?
Observational (n=32)
Does nebulised salbutamol improve respiratory resistance in wheezing children aged 7 months to 3 years 7 months?
Nebulised salbutamol appears ineffective at reducing respiratory resistance in wheezing children under 18 months of age, but is effective in those over 20 months.
Answers are grounded in this paper and cite their sources.
Salbutamol may not reduce resistance in wheezing infants <18 months; leaves open age-specific randomized trials before practice change.
Using a modification of the forced oscillation technique we have measured respiratory resistance before and after nebulised salbutamol therapy in 32 wheezing children aged 7 months to 3 years 7 monts. 12 of the children were also studied in a total body plethysmograph. No child under 18 months of aged showed a greater than 5% fall in resistance or any fall in thoracic gas volume. In contrast, 18 of 20 children over 20 months of age showed a fall in resistance greater than 20%.
No takes yet. Share an insight, caveat, or question.
Lenney et al. (1978) conducted an observational in wheezing (n=32). Nebulised salbutamol vs. Baseline (before therapy) was evaluated on Fall in respiratory resistance. Nebulised salbutamol therapy produced a >20% fall in respiratory resistance in 18 of 20 wheezing children over 20 months of age, but no child under 18 months showed a >5% fall.
Synapse has enriched 10 related papers. Consider them for comparative context: